Faslodex Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

FASLODEX: Solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FULVESTRANT (ful VES trant) blocks the effects of estrogen. It is used to treat breast cancer in women past the age of menopause.

In-Depth Information

FASLODEX 50mg/ml Solution for Injection

NDC: 003100720
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
FASLODEX 50mg/ml Solution for Injection

Reported Side Effects for FASLODEX 50mg/ml Solution for Injection

Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Eyes Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
<11.8%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vaginal Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Blurred Vision Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Secretion Of Tears Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Nose Bleed Incidence:
<7.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Low Platelet Count Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
<16.1%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
3.2-5.5%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
3.5-16.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
4.0-22.7%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
4.4-14.9%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
5.0-6.4%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
5.3-10.4%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
5.7%*
Severity: MODERATE
Onset: DELAYED
Hot Flashes Incidence:
5.9-17.7%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
6.4%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
6.7-20.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
6.9%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
6.9%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
7.1%*
Severity: MODERATE
Onset: EARLY
Bone Pain Incidence:
7.5-15.8%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
7.5-14.4%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
7.8-8.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
9.1-11.6%*
Severity: MILD
Onset: RAPID
Pelvic Pain Incidence:
9.9%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with FASLODEX

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5